Amedisys Announces Major Executive Leadership Shake-Up

An ongoing effort to improve its balance sheet has led Amedisys Inc. (NASDAQ: AMED) to an extensive leadership overhaul at the executive level. In April 2014, Amedisys agreed to pay $150 million to the federal government, resolving allegations that the company provided medically unnecessary services to Medicare beneficiaries. As the company tries to bounce back, it […]

Lawsuit Claims Amedisys Hid Overbilling to Sell Hospice Business

Amedisys, Inc.—one of the nation’s largest home health and hospice providers—hid that it was overbilling Medicare in order to quickly sell off a part of its hospice business last year, according to allegations in a recently filed lawsuit. The deal in question is the sale of Amedisys Wyoming, LLC, to Frontier Home Health and Hospice, […]

Amedisys Alerts 6,900 Home Health Patients of Possible Data Breach

Amedisys, Inc. (NASDAQ: AMED) is currently in the process of notifying federal and state agencies as well as 6,909 individuals who may have had their personal information subject to a data breach. Earlier this month, the Baton Rouge, La.-based home health and hospice provider reported the results of an extensive risk management process to locate approximately […]

Home Health Giant Amedisys Bounces Back After $150 Million Settlement

One of the nation’s largest home health providers, Amedisys, has recovered from a large legal settlement and is positioning itself for success with new payor organizations, company leaders said in announcing fourth quarter 2014 earnings this week. In April 2014, Amedisys agreed to pay $150 million to the federal government, resolving charges that it provided […]

Layoffs, Closures and Threats: Home Health Care News’ Most Popular Stories of 2014

Policy changes, blockbuster mergers and acquisitions, as well as layoffs, closings and caregiver labor debates characterized the home health and hospice sector in 2014. Mounting reimbursement pressures forced some of the nation’s largest provider to shutter operations and lay off hundreds at some locations, while other big players turned to the acquisition market to fuel their […]

Private Equity Pegged as New Multi-Billion Dollar Gentiva Bidder

The ongoing purchase offers and subsequent rejections between Kindred Healthcare, Inc. (NYSE:KND) and Gentiva Health Services, Inc. (NASDAQ:GTIV) has invited a new player into the mix, one that analysts assume is likely a private equity suitor for the latter home health giant. Monday, Kindred solicited its newest proposal to Gentiva in response to the company’s […]

Probe Into Amedisys Concludes With No SEC Action

A four-year Securities and Exchange Commission (SEC) investigation into one of the nation’s leading home health care companies has concluded, and SEC says it will take no further action against the provider. SEC staff recently advised Amedisys, Inc. (Nasdaq:AMED) that the investigation by the SEC related to the company’s operations and participation in the Medicare program […]

Gentiva Rejects Kindred Offer, Again

Gentiva Health Services (NASDAQ:GTIV) has rejected Kindred Healthcare’s (NYSE:KND) latest bid to buy the company, saying it significantly undervalues Gentiva and is not in the best interests of its shareholders.  In the most recent bid, Kindred offered to acquire all outstanding shares of Gentiva’s common stock for $14.50 per share, making the deal a $1.7 billion acquisition. […]

Kindred to Gentiva: Don’t Acquire Amedisys

In the latest move of Kindred Healthcare’s ongoing quest to buy Gentiva Health Services, Kindred (NYSE:KND) has sent a letter to the Gentiva (NASDAQ:GTIV) board of directors, telling the company to reconsider its pursuits of acquiring Amedisys Inc. (NASDAQ:AMED). The acquisition, Kindred writes, would disenfranchise Gentiva shareholders. Instead, Kindred urges the board to discuss its “highly […]

Amedisys Proposes Settlement Resolving Insider Trading Suit

A proposed settlement resolving a civil lawsuit accusing home health and hospice company Amedisys, Inc. (NASDAQ:AMED) of insider trading has been preliminarily approved by the United States District Court for the Middle District of Louisiana. Shareholders filed a federal lawsuit, Robert F. Bach, et al., v Amedisys, Inc., et all., against Amedisys alleging that some of […]